| Date | Form | Description | Docs | XBRL | Pages |
| 08/17/09 | 8-K | Current report filing |
|
6 | |
| 07/01/09 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/18/09 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
30 | |
| 06/10/09 | NT 10-Q | Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB |
|
3 | |
| 03/12/09 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
28 | |
| 01/21/09 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans |
|
11 | |
| 01/16/09 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
59 | |
| 01/15/09 | NT 10-K | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT |
|
3 | |
| 12/05/08 | 5 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/04/08 | 8-K | Current report filing |
|
2 |
Latest News & Events
Anixa Biosciences Reports Encouraging Patient Survival Observations in Ovarian Cancer CAR-T Trial; Achieves Regulatory Approval Enabling Major Dose Escalation
Read More...Anixa Biosciences Secures United States Adopted Names Council Approval of Non-Proprietary Name for its CAR-T Therapy, a Key Step Toward Future Commercialization
Read More...Anixa Biosciences Receives Notice of Allowance from Mexican Institute of Industrial Property (IMPI) for Patent Covering Breast Cancer Vaccine Technology
Read More...